Richard Finn
MD
Professor of Medicine, Director Signal Transduction Program
👥Biography 个人简介
Richard Finn performed foundational preclinical work identifying CDK4/6 inhibitor sensitivity in luminal breast cancer and led the PALOMA-1/2/3 trials of palbociclib that delivered the first CDK4/6 inhibitor approval. His translational work continues to guide patient selection for CDK4/6 therapies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Richard Finn 的研究动态
Follow Richard Finn's research updates
留下邮箱，当我们发布与 Richard Finn（UCLA Jonsson Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment